⚠️ This AI-generated report synthesizes publicly available information. AI can make mistakes. Please double check information in this report.
Consumer Defensive | Household & Personal Products
📊 The Bottom Line
Colgate-Palmolive is a high-quality consumer defensive business with an extensive portfolio of essential household and personal care products. Its strong brand recognition and global distribution provide a durable moat, but growth hinges on innovation and expansion in emerging markets. The company generates consistent cash flow and pays a reliable dividend.
⚖️ Risk vs Reward
At its current US$85.12 price, Colgate-Palmolive appears fairly valued to slightly overvalued against analyst average targets around US$97. The stable nature of its products offers downside protection, while potential upside is tied to successful product launches and market share gains in key segments. Risk-reward is balanced for long-term, dividend-focused investors.
🚀 Why CL Could Soar
⚠️ What Could Go Wrong
Oral Care
45%
Toothpaste, toothbrushes, and mouthwash products globally.
Personal Care
25%
Soaps, shower gels, shampoos, conditioners, deodorants, skin health.
Home Care
10%
Dishwashing detergents, fabric conditioners, household cleaners.
Pet Nutrition (Hill's)
20%
Specialized pet food under Hill's Science Diet and Prescription Diet.
🎯 WHY THIS MATTERS
Colgate-Palmolive's diversified product portfolio in essential consumer goods provides stability and resilience. The strong global presence, particularly in fast-growing emerging markets, offers avenues for continued, albeit moderate, revenue expansion and consistent cash flow generation.
Colgate-Palmolive's portfolio of globally recognized brands such as Colgate, Palmolive, and Hill's commands significant consumer trust and loyalty. This allows the company to maintain premium pricing power and strong market share in highly competitive consumer goods categories, making it challenging for new entrants to compete effectively purely on price. The long history and consistent quality foster deep-seated consumer preferences.
Operating in over 200 countries, Colgate-Palmolive leverages an extensive global distribution network. International sales comprise approximately 70% of total revenue, with 45% derived from emerging regions. This vast infrastructure enables efficient product delivery and deep market penetration, providing substantial cost advantages in manufacturing, logistics, and advertising that are difficult for smaller rivals to replicate.
Colgate-Palmolive consistently invests in research and development to introduce innovative products, especially in oral care and specialized pet nutrition. This focus allows for the development of differentiated offerings that address evolving consumer needs, such as advanced whitening toothpaste or therapeutic pet foods. Such innovation helps sustain competitive advantage, secure patents, and maintain a leading edge in critical market segments.
🎯 WHY THIS MATTERS
These advantages collectively create a formidable moat around Colgate-Palmolive's business, enabling consistent profitability and resilience against economic downturns. The combination of strong brands, global reach, and continuous innovation helps the company sustain its market leadership and generate reliable returns for shareholders over the long term.
Noel R. Wallace
Chairman, CEO & President
Noel R. Wallace, 61, serves as Chairman, CEO & President. He has been instrumental in driving growth and strategic initiatives, focusing on innovation, digital transformation, and expanding the company's global footprint. His leadership is key to navigating the competitive consumer goods landscape and delivering shareholder value.
The household and personal products industry is highly competitive, characterized by strong global players, intense brand rivalry, and significant spending on advertising and R&D. Competitors vie for market share based on product innovation, pricing, brand recognition, and extensive distribution networks. The market also faces pressure from private-label brands and smaller, agile direct-to-consumer companies.
📊 Market Context
Competitor
Description
vs CL
Procter & Gamble (P&G)
A global consumer goods giant with a vast portfolio spanning beauty, grooming, health care, fabric & home care, and baby, feminine & family care.
P&G is a direct competitor in many categories like oral care (Crest), personal care (Gillette), and home care (Tide), often leveraging greater marketing spend and retail presence.
Unilever PLC
A multinational consumer goods company offering food & refreshment, home care, and beauty & personal care products globally.
Unilever competes directly with Colgate in personal care (Dove, Axe) and home care (Sunlight), focusing on similar markets with strong local brand adaptation and sustainability initiatives.
Kimberly-Clark Corporation
Focuses on personal care (Huggies, Kotex) and professional products, with a smaller overlap in household essentials.
While having less direct product overlap, Kimberly-Clark competes for shelf space and consumer attention in the broader consumer staples sector, especially in hygiene and personal care.
7
6
6
Low Target
US$87
+2%
Average Target
US$97
+14%
High Target
US$105
+23%
Closing: US$85.12 (20 Mar 2026)
High Probability
Colgate's iconic brands lead to consistent demand and the ability to raise prices without significant volume loss, protecting margins against inflation and increasing revenue by 2-4% annually.
Medium Probability
The Hill's Pet Nutrition segment continues to outperform, driven by premiumization trends in pet care. Sustained double-digit growth could contribute an additional 1-2% to overall revenue growth.
Medium Probability
Targeted acquisitions of complementary niche brands in high-growth areas like natural personal care or specialized health products could open new revenue streams, adding 3-5% to sales over 3-5 years.
Medium Probability
Growing popularity of cheaper private-label alternatives could force Colgate to lower prices, leading to a 5-10% decline in gross margins across key categories, impacting overall profitability.
High Probability
Significant exposure to emerging markets makes Colgate vulnerable to adverse foreign exchange rate movements, which could reduce reported international sales and earnings by 3-7% annually.
High Probability
Persistent increases in raw material, packaging, and transportation costs, coupled with supply chain disruptions, could erode operating margins by 1-2 percentage points, squeezing net income.
Colgate-Palmolive's entrenched brands and global presence make it a compelling long-term hold for investors prioritizing stability and dividend income. Its defensibility against economic cycles is strong, supported by non-discretionary products. While growth may be modest, management's focus on innovation and emerging markets provides avenues for incremental expansion. Key risks include intense competition and currency volatility. The ability to maintain brand relevance and adapt to changing consumer preferences will be crucial for sustained success over the next decade.
Metric
31 Dec 2025
31 Dec 2024
31 Dec 2023
Income Statement
Revenue
US$20.38B
US$20.10B
US$19.46B
Gross Profit
US$12.25B
US$12.16B
US$11.33B
Operating Income
US$4.23B
US$4.33B
US$4.08B
Net Income
US$2.13B
US$2.89B
US$2.30B
EPS (Diluted)
2.63
3.51
2.77
Balance Sheet
Cash & Equivalents
US$1.29B
US$1.10B
US$0.97B
Total Assets
US$16.33B
US$16.05B
US$16.39B
Total Debt
US$8.55B
US$8.51B
US$9.06B
Shareholders' Equity
US$0.05B
US$0.21B
US$0.61B
Key Ratios
Gross Margin
60.1%
60.5%
58.2%
Operating Margin
20.8%
21.5%
21.0%
Return on Equity
3948.15
1362.74
377.67
Metric
Annual (31 Dec 2026)
Annual (31 Dec 2027)
EPS Estimate
US$3.88
US$4.15
EPS Growth
+5.2%
+6.9%
Revenue Estimate
US$21.3B
US$22.0B
Revenue Growth
+4.3%
+3.4%
Number of Analysts
19
19
| Metric | Value | Description |
|---|---|---|
| P/E Ratio (TTM) | 32.37 | The trailing Price-to-Earnings ratio measures the current share price relative to the company's earnings per share over the past twelve months, indicating how much investors are willing to pay for each dollar of earnings. |
| Forward P/E | 20.52 | The forward Price-to-Earnings ratio uses estimated future earnings, offering a view of valuation based on expected profitability. |
| Price/Sales (TTM) | 3.35 | The trailing Price-to-Sales ratio compares the company's market capitalization to its revenue over the past twelve months, useful for valuing companies with volatile earnings or high growth. |
| Price/Book (MRQ) | 1270.45 | The Price-to-Book ratio compares the market value of a company's shares to its book value, indicating how much investors are willing to pay for each dollar of net assets. |
| EV/EBITDA | 15.55 | Enterprise Value to EBITDA measures the total value of a company (including debt) relative to its earnings before interest, taxes, depreciation, and amortization, often used to compare companies across different capital structures. |
| Return on Equity (TTM) | 4.97 | Return on Equity measures a company's profitability in relation to the equity invested by its shareholders, indicating how efficiently management is using shareholder investments to generate profits. |
| Operating Margin | 0.20 | Operating Margin indicates how much profit a company makes from its operations before interest and taxes, expressed as a percentage of revenue, reflecting operational efficiency. |